NCT01512563

Patency and Safety of the Drug Eluting Covered Biliary Stent Comparing to the Common Covered Biliary Stent

Clinical Trial Comparing Patency and Safety of the Paclitaxel Eluting Covered Metallic Biliary Stent(Niti-S Mira-Cover Biliary Stent ) to the Common Covered Metallic Biliary Stent(Niti-S Biliary Stent)

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 106 (actual)
• Sponsor: Taewoong Medical Co., Ltd. · Industry
• Sex: All
• Age: 19 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

Paclitaxel covered metal biliary stent extents their patency rate comparing to the Common Covered Metallic Biliary Stent.

Detailed description

Paclitaxel covered metal biliary stent(Mira-Cover Biliary Stent) extents their patency rate comparing to the Common Covered Metallic Biliary Stent(Niti-S Biliary Stent.

Conditions

• Biliary Stricture
• Malignant Neoplasms

Interventions

Type	Name	Description
DEVICE	Biliary stent	palliative treatment for malignant patients

Timeline

• Start date: 2007-02-01
• Primary completion: 2010-02-01
• Completion: 2010-02-01
• First posted: 2012-01-19
• Last updated: 2020-03-11

Locations

3 sites across 1 country: South Korea